🇺🇸 FDA
Patent

US 7951909

Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide

granted A61KA61K39/00A61P

Quick answer

US patent 7951909 (Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide) held by United Biomedical, Inc. expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Biomedical, Inc.
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K39/00, A61P, A61P25/28, A61P37/04